Combination of atezolizumab and chidamide to maintain long-term remission in refractory metastatic extranodal natural killer/T-cell lymphoma: A case report

doi:10.12998/wjcc.v10.i5.1609

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 5

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3653)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

233

WORD

HTML

1892

Figures (1-2)

331

Tables (1-1)

309

Sum=2860

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

328

Download

465

Sum=793

Feb 16, 2022 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Feb 16, 2022; 10(5): 1609-1616
Published online Feb 16, 2022. doi: 10.12998/wjcc.v10.i5.1609

Full Size Figure Download Figure

Figure 1 Photomicrographs of the left nasal cavity biopsy demonstrating extranodal natural killer/T-cell lymphoma. Immunohistochemical staining showed that the tissue of the left nasal cavity mass was positive for CD3, TIA-1, Ki67, and CD56 but negative for CD20.

Citation: Wang J, Gao YS, Xu K, Li XD. Combination of atezolizumab and chidamide to maintain long-term remission in refractory metastatic extranodal natural killer/T-cell lymphoma: A case report. World J Clin Cases 2022; 10(5): 1609-1616
URL: https://www.wjgnet.com/2307-8960/full/v10/i5/1609.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i5.1609